Skip to content
2000
Volume 28, Issue 1
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

In the drug development, the formation of highly selective ligands has been unsuccessful in the treatment of central nervous system disorders. Multi-target ligands, from the polypharmacology paradigm, are being proposed as treatments for these complex disorders, since they offer enhanced efficacy and a strong safety profile. Natural products are the best examples of multi-target compounds, so they are of high interest within this paradigm. Additionally, recent research on psychoactive drugs of natural origin, such as ayahuasca and cannabis, has demonstrated the promising therapeutic potential for the treatment of some psychiatric and neurological disorders. In this text, we describe how research on psychoactive drugs can be effectively combined with the polypharmacology paradigm, providing ayahuasca and cannabis research as examples. The advantages and disadvantages are also discussed.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867326666191212103330
2021-01-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867326666191212103330
Loading

  • Article Type:
    Review Article
Keyword(s): ayahuasca; cannabis; multi-target; plant; Polypharmacology; psychoactive; therapeutic
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test